Decreasing Cumulative Incidence of End-Stage Renal Disease in Young Patients With Type 1 Diabetes in Sweden: A 38-Year Prospective Nationwide Study

Authors:
  • SRSwedish Childhood Diabetes Study Group and the Swedish Renal Register
    Swedish Childhood Diabetes Study Group and the Swedish Renal Register
  • TLTorbjörn Lind
    Torbjörn Lind
  • KCKatarina Steen Carlsson
    Katarina Steen Carlsson
  • SPSofie Persson
    Sofie Persson
  • EPEmma Persson
    Emma Persson

Abstract
OBJECTIVE: Diabetic nephropathy is a serious complication of type 1 diabetes. Recent studies indicate that end-stage renal disease (ESRD) incidence has decreased or that the onset of ESRD has been postponed; therefore, we wanted to analyze the incidence and time trends of ESRD in Sweden. RESEARCH DESIGN AND METHODS: In this study, patients with duration of type 1 diabetes >14 years and age at onset of diabetes 0–34 years were included. Three national diabetes registers were used: the Swedish Childhood Diabetes Register, the Diabetes Incidence Study in Sweden, and the National Diabetes Register. The Swedish Renal Registry, a national register on renal replacement therapy, was used to identify patients who developed ESRD. RESULTS: We found that the cumulative incidence of ESRD in Sweden was low after up to 38 years of diabetes duration (5.6%). The incidence of ESRD was lower in patients with type 1 diabetes onset in 1991–2001 compared with onset in 1977–1984 and 1985–1990, independent of diabetes duration. CONCLUSIONS: The risk of developing ESRD in Sweden in this population is still low and also seems to decrease with time.

This publication has 31 references indexed in Scilit: